drugset / Trial / NCT03139240

Opioid Analgesia for MAB

NCT03139240 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

Our primary objective will be to determine if a strong opioid, oxycodone, given at a dose recommended for severe pain in addition to ibuprofen decreases maximum pain scores compared to ibuprofen and placebo in women undergoing medical abortion (MAB). Results of this study will help future providers understand whether prescribing opioids are an important adjunct for pain control in women undergoing MAB.

Timeline

Start
2017-05-01
Primary completion
2018-05-31
Completion
2018-05-31

Outcome

Missed primary endpoint

paper We found no difference between groups in median maximum pain scores (placebo 8 [range 1-10], oxycodone 8 [range 2-10], P=.92) PMID 31764725 ↗

paper Oxycodone does not reduce the maximum level of pain experienced by women undergoing medical abortion up to 10 0/7 weeks of gestation PMID 31764725 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxycodone Other / unclassified 10 mg Oral

Indications

No indication recorded.